Company Filing History:
Years Active: 2013-2017
Title: Jwu-Lai Yeh: Innovator in Bone Health Solutions
Introduction
Jwu-Lai Yeh is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of bone loss diseases. With a total of 2 patents, his work focuses on innovative solutions that address critical health issues.
Latest Patents
One of Jwu-Lai Yeh's latest patents is related to the TMD1 protein for treating bone loss diseases. This invention outlines a method for treating bone loss conditions by administering a pharmaceutically effective amount of a composition that includes thrombomodulin lectin-like domain (TMD1). Another notable patent involves a theophylline derivative that inhibits osteoporosis. This derivative is characterized by its pharmaceutical functions that protect against bone resorption and inflammatory mediator infiltration.
Career Highlights
Throughout his career, Jwu-Lai Yeh has been associated with Kaohsiung Medical University, where he has contributed to research and development in the medical field. His work has garnered attention for its potential impact on treating osteoporosis and other bone-related disorders.
Collaborations
Jwu-Lai Yeh has collaborated with notable colleagues such as Tsung-Lin Cheng and Mei-Ling Ho. Their combined efforts have further advanced the research in bone health and treatment methodologies.
Conclusion
Jwu-Lai Yeh's innovative patents and contributions to medical science highlight his dedication to improving health outcomes for individuals suffering from bone loss diseases. His work continues to inspire advancements in the field of osteoporosis treatment.